Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Treatment OutcomeBlood Component RemovalCombined Modality TherapyBone Marrow TransplantationGraft SurvivalCyclophosphamideBusulfanHematopoietic Stem CellsMyeloablative AgonistsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsStem CellsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingEtoposideHistocompatibilityThiotepaPOEMS SyndromeWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicRetrospective StudiesVidarabineImmunosuppressive AgentsHematopoiesisSalvage TherapyAmyloidosisLeukemiaSurvival RateIfosfamideSurvival AnalysisCarmustineVincristineGraft vs Leukemia EffectCytarabineHodgkin DiseaseBlood CellsLeukemia, Myeloid, AcuteTime FactorsPlatelet CountMyelodysplastic SyndromesCytomegalovirus InfectionsAnemia, AplasticBlood Cell CountLymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytophagocytosisLymphocyte DepletionLiver TransplantationNeoplasmsFollow-Up StudiesFatal OutcomeFeasibility StudiesHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellLivedo ReticularisPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensDoxorubicinCyclosporineBone MarrowImmunophenotypingBlood DonorsImmunosuppressionBone Marrow PurgingProspective StudiesMesenchymal Stem Cell TransplantationRecombinant ProteinsPrednisoneLymphoma, T-CellPilot ProjectsCarboplatinBone Marrow DiseasesPrognosisT-LymphocytesAntigens, CDCell TransplantationAntineoplastic AgentsTransplantation Immunology